Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


22.04.2019

1 BMJ
2 Cancer Res
1 Clin Cancer Res
1 Eur J Dermatol
1 J Am Acad Dermatol
1 J Immunother
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ


  1. Seven days in medicine: 16-22 January 2019.
    BMJ. 2019;364:l320.
    PubMed     Text format    


    Cancer Res

  2. EMMONS MF, Faiao-Flores F, Sharma R, Thapa R, et al
    HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy.
    Cancer Res. 2019 Apr 15. pii: 0008-5472.CAN-19-0040.
    PubMed     Text format     Abstract available

  3. SHAH R, Singh SJ, Eddy K, Filipp FV, et al
    Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1(+) Melanoma.
    Cancer Res. 2019;79:1799-1809.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. COHEN JV, Sullivan RJ
    Developments in the space of new MAPK pathway inhibitors for BRAF-mutant melanoma.
    Clin Cancer Res. 2019 Apr 16. pii: 1078-0432.CCR-18-0836.
    PubMed     Text format     Abstract available


    Eur J Dermatol

  5. GRAN F, Goebeler M, Gesierich A
    Erythema multiforme-like rash upon anti-melanoma therapy with BRAF and MEK inhibitors.
    Eur J Dermatol. 2019;29:107-108.
    PubMed     Text format    


    J Am Acad Dermatol

  6. ZAFFRAN K, Lazovich D, Boull C, Vogel RI, et al
    Patient satisfaction with patient-provider interactions at time of diagnosis among early stage melanoma survivors - a cross-sectional survey.
    J Am Acad Dermatol. 2019 Apr 12. pii: S0190-9622(19)30600.
    PubMed     Text format    


    J Immunother

  7. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.
    J Immunother. 2019 Apr 10. doi: 10.1097/CJI.0000000000000264.
    PubMed     Text format     Abstract available


    N Engl J Med

  8. RAJKOMAR A, Dean J, Kohane I
    Machine Learning in Medicine.
    N Engl J Med. 2019;380:1347-1358.
    PubMed     Text format    


    PLoS One

  9. DATAR I, Kalpana G, Choi J, Basuroy T, et al
    Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells.
    PLoS One. 2019;14:e0204387.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: